Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Pharma
BMS-Hengrui, Takeda layoffs, Daiichi—Fierce Pharma Asia
BMS and Hengrui signed a deal worth up to $15.2 billion. Takeda will cut 4,500 jobs in FY2026. Daiichi sets ambitious oncology goal.
Angus Liu
May 15, 2026 8:30am
Rigel snags Veppanu license from Pfizer, Arvinas for $85M
May 12, 2026 11:35am
Summit, UCB-Candid, J&J—Fierce Pharma Asia
May 8, 2026 8:30am
Fierce Biotech
Regeneron rides into radiopharma via $2.1B biobucks Telix pact
Apr 13, 2026 7:24am
Vertex taps Halozyme in $15M upfront biologics drug delivery deal
Apr 7, 2026 10:17am
Novavax bets on ‘amplification strategy’ with Sanofi, Pfizer deals
Apr 6, 2026 8:37am
